ReviewFrontiers in pharmacology2017
The Early Awareness and Alert System in Sweden: History and Current Status.
Review in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir.Revista do Instituto de Medicina Tropical de Sao Paulo · 2018Trial
- Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027.Health economics review · 2025Article
- Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2025Article
- Knowledge management tools and mechanisms for evidence-informed decision-making in the WHO European Region: a scoping review.Health research policy and systems · 2023Article
- Trends in the utilization of medicines sold in the private sector post- registration in South Africa and the implications for similar countries.BMC public health · 2023Article
- Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria.Frontiers in pharmacology · 2021Article
- Article
- Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications.Expert review of clinical pharmacology · 2021Article
- A Nationwide Study of Prevalence Rates and Characteristics of 199 Chronic Conditions in Denmark.PharmacoEconomics - open · 2020Article
- Forecasting drug utilization and expenditure: ten years of experience in Stockholm.BMC health services research · 2020Article
- Editorial: New Horizons in Health-Promoting Technologies: From Development to Rational Use.Frontiers in pharmacology · 2020Article
- Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province.Frontiers in pharmacology · 2020Article
- Pre-reimbursement: early assessment for coverage decisions.Wiener medizinische Wochenschrift (1946) · 2019Article
- Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1-Biosimilar and Originator Infliximab in the Hospital Setting.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2019Article
- Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System.Applied health economics and health policy · 2019Article
- Horizon scanning in Brazil: outputs and repercussions.Revista de saude publica · 2019Article
- Medicine Shortages: Gaps Between Countries and Global Perspectives.Frontiers in pharmacology · 2019Article
- Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.Applied health economics and health policy · 2018Article
- Clinical and Financial Implications of Medicine Consumption Patterns at a Leading Referral Hospital in Kenya to Guide Future Planning of Care.Frontiers in pharmacology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.